Sentinel Node Mapping for Breast Cancer: Progress to Date and Prospects for the Future

Surgical Oncology Clinics of North America

Volumn 16, Issue 1, 2007, Pages 55-70

  Mabry, Helen ^a,b   Giuliano, Armando E ^a,b  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b Joyce Eisenberg Keefer Breast Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; HUMAN; INVASIVE CARCINOMA; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PATIENT CARE; REVIEW; SENTINEL LYMPH NODE; STANDARD;

AXILLA; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY;

EID: 33847264897     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2006.10.015     Document Type: Review

References (60)

1. Carter C.L., Allen C., and Henson D.E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63 (1989) 181-187
2. Fisher E.R., Sass R., and Fisher B. Pathologic findings from the National Surgical Adjuvant Project for breast cancers (protocol no. 4). Cancer 53 (1984) 712-723
3. Wilke L.G., McCall L.M., Posther K.E., et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13 4 (2006) 491-500
4. Lyman G.H., Giuliano A.E., Somerfield M.R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 30 (2005) 7703-7720
5. Schwartz G.F., Giuliano A.E., Veronesi U., et al. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 94 10 (2002) 2542-2551
6. Silverstein M.J., Lagios M.D., Recht A., et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg 201 4 (2005) 586-597
7. Gould E.A., Winship T., Philbin P.H., et al. Observations of a 'sentinel node' in cancer of the parotid. Cancer 13 (1960) 77-78
8. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 (1977) 456-466
9. Chiappa S., Uslenghi C., Bonadonna G., et al. Combined testicular and foot lymphangiography in testicular carcinomas. Surg Gynecol Obstet 123 (1966) 10-14
10. Kett K., Varga G., Lukacs L., et al. Direct lymphography of the breast. Lymphology 1 (1970) 3-12
11. Christensen B., Blichert-Toft M., Siemssen O.J., et al. Reliability of axillary lymph node scintiphotography in suspected carcinoma of the breast. Br J Surg 67 (1980) 667-668
12. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 4 (1992) 392-399
13. Giuliano A.E., Jones R.C., Brennan M., et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15 (1997) 2345-2350
14. Giuliano A.E., Kirgan D.M., Guenther J.M., et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-398
15. Veronesi U., Paganelli G., and Viale G. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 (2003) 546-553
16. Harlow S.P., Krag D., Julian T.B., et al. Prerandomization surgical training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 Trial, a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 241 (2005) 48-54
17. McCready D.R., Yong W.S., Ng A.K., et al. Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates. J Natl Cancer Inst 96 (2004) 873-875
18. Kim T., Agboola O., Giuliano A., et al. Lymphatic mapping and sentinel node biopsy in early-stage breast cancer: a meta-analysis. Cancer 106 1 (2006) 4-16
19. Turner R.R., Ollila D.W., Stern S., et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 23 (1999) 263-267
20. Hansen N.M., Grube B.J., Giuliano A.E., et al. Clinical significance of axillary micrometastases in breast cancer: how small is too small. [abstract 91]. Proc Am Soc Clin Oncol 20 (2001) 20A
21. Calhoun K.E., Hansen N.M., Turner R.R., et al. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am J Surg 190 4 (2005) 588-591
22. Chagpar A., Middleton L.P., Sahin A.A., et al. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 103 8 (2005) 1581-1586
23. Van Zee K.J., Manasseh D.E., Bevilacqua J.L., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10 10 (2003) 1140-1151
24. Mabry H., and Giuliano A.E. The practical value of prediction: a semi-reliable assistant. Ann Surg Oncol 13 3 (2006) 282-284
25. Giuliano A.E., Haigh P.I., Brennan M.B., et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18 13 (2000) 2553-2559
26. Naik A.M., Fey J., Gemgignani M., et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection. Ann Surg 240 3 (2004) 462-471
27. Palesty J.A., Foster J.M., Hurd T.C., et al. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. J Surg Oncol 93 2 (2006) 129-132
28. De Kanter A.Y., Menke-Pluymers M.M., Wouters M.W., et al. 5-Year follow up of sentinel node negative breast cancer patients. Eur J Surg Oncol 32 3 (2006) 282-286
29. Posther K.E., McCall L.M., Blumencranz P.W., et al. Sentinel node skills verification and surgeon performance data from a multicenter clinical trial for early-stage breast cancer. Ann Surg 242 4 (2005) 593-602
30. Cox C.E., Salud C.J., Cantor A., et al. Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg 193 6 (2001) 593-600
31. Cox C.E., Bass S.S., Boulware D., et al. Implementation of new surgical technology: outcome measures for lymphatic mapping of breast carcinoma. Ann Surg Oncol 6 6 (1999) 553-561
32. Derossis A.M., Fey J., Yeung H., et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 193 5 (2001) 473-478
33. Raut C.P., Daley D., Hunt K., et al. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol 22 3 (2004) 567-568
34. Lucci Jr. A., Keleman P.R., Miller III C., et al. National practice patterns of sentinel lymph node dissection for breast carcinoma. [comment]. J Am Coll Surg 192 (2001) 453-458
35. Morrow M., Rademaker A.W., Bethke K.P., et al. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery 126 (1999) 714-720
36. Diaz N.M., Cox C.E., Ebert M., et al. Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Path 28 12 (2005) 1641-1645
37. Temple L.K., Baron R., Cody III H.S., et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 28 (2002) 705-710
38. Moskovitz A.H., Anderson B.O., Yeung R.S., et al. Axillary web syndrome after axillary dissection. Am J Surg 181 (2001) 434-439
39. Brogi E., Torres-Matundan E., Tan L.K., et al. The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 1133 breast cancer patients. Ann Surg Oncol 12 2 (2005) 173-180
40. Turner R.R., Hansen N.M., Stern S.L., et al. Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol 112 5 (1999) 627-634
41. King T.A., Ganaraj A., Fey J.V., et al. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy. Cancer 101 5 (2004) 926-933
42. Dupont E.L., Kuhn M.A., McCann C., et al. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 180 4 (2000) 274-277
43. Yen T.W., Hunt K.K., Ross M.I., et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200 4 (2005) 516-526
44. Chung M.H., Ye W., and Giuliano A.E. Role for sentinel lymph node dissection in the management of large (>5 cm) invasive breast cancer. Ann Surg Oncol 8 9 (2001) 688-692
45. Wong S.L., Chao C., Edwards M.J., et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Ann Surg 67 6 (2001) 522-526
46. Mamounas E.P., Brown A., Anderson S., et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27. J Clin Oncol 23 12 (2005) 2694-2702
47. Breslin T.M., Cohen L., Sahin A., et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18 (2000) 3480-3486
48. Nason K.S., Anderson B.O., Byrd D.R., et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 89 (2000) 2187-2194
49. Sabel M.S., Schott A.F., Kleer C.K., et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. Am J Surg 186 (2003) 102-105
50. Cutler S.J., Axtell L.M., Schottenfeld D., et al. Clinical assessment of lymph nodes in carcinoma of the breast. Surg Gynecol Obstet 131 (1970) 41-52
51. Fisher B., Wolmark N., and Banes M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 152 (1981) 765-772
52. De Freitas Jr. R., Costa M.V., Schneider S.V., et al. Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 17 (1991) 240-244
53. Vaidya J.S., Vyas J.J., Thakur M.H., et al. Role of ultrasound to detect axillary node involvement in operable breast cancer. Eur J Surg Oncol 22 (1996) 140-143
54. Specht M.C., Fey J.V., Borgen P.I., et al. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?. J Am Coll Surg 200 (2005) 10-14
55. Port E.R., Fey J.V., Cody III H.S., et al. Sentinel lymph node biopsy in patients with male breast carcinoma. Cancer 91 (2001) 319-323
56. Gentilini O., Cremonesi M., and Trifiro G. Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 15 (2004) 1348-1351
57. Tousimis E., Van Zee K.J., Fey J.V., et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg 197 4 (2003) 529-535
58. Newman E.A., Cimmino V.M., Sabel M.S., et al. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol 13 1 (2006) 52-57
59. Taback B., Nguyen P., Hansen N., et al. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol 13 8 (2006) 1099-1104
60. Port E.R., Fey J., and Gemignani M.L. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 195 2 (2002) 167-172